Galera Therapeutics Inc.
0.05
0.00 (5.26%)
At close: Jan 15, 2025, 3:30 PM
0.05
0.87%
Pre-market Jan 10, 2025, 09:30 AM EST

Galera Therapeutics Statistics

Share Statistics

Galera Therapeutics has 54.39M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding 54.39M
Shares Change (YoY) n/a
Shares Change (QoQ) 0%
Owned by Institutions (%) n/a
Shares Floating 39.94M
Failed to Deliver (FTD) Shares 2
FTD / Avg. Volume 0%

Short Selling Information

The latest short interest is 2.12M, so 3.9% of the outstanding shares have been sold short.

Short Interest 2.12M
Short % of Shares Out 3.9%
Short % of Float 5.32%
Short Ratio (days to cover) 1.16

Valuation Ratios

The PE ratio is -0.11 and the forward PE ratio is -0.04.

PE Ratio -0.11
Forward PE -0.04
PS Ratio 0
Forward PS null
PB Ratio -0.05
P/FCF Ratio -0.14
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Galera Therapeutics Inc..

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.36, with a Debt / Equity ratio of -0.01.

Current Ratio 4.36
Quick Ratio 4.36
Debt / Equity -0.01
Total Debt / Capitalization -0.96
Cash Flow / Debt -35.88
Interest Coverage 0

Financial Efficiency

Return on equity (ROE) is 0.45% and return on capital (ROIC) is 36.13%.

Return on Equity (ROE) 0.45%
Return on Assets (ROA) -2.26%
Return on Capital (ROIC) 36.13%
Revenue Per Employee 0
Profits Per Employee -8.44M
Employee Count 7
Asset Turnover 0
Inventory Turnover 0

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by -76.16% in the last 52 weeks. The beta is 1.99, so Galera Therapeutics 's price volatility has been higher than the market average.

Beta 1.99
52-Week Price Change -76.16%
50-Day Moving Average 0.04
200-Day Moving Average 0.1
Relative Strength Index (RSI) 57.28
Average Volume (20 Days) 241.07K

Income Statement

Revenue n/a
Gross Profit -259.00K
Operating Income -46.95M
Net Income -59.08M
EBITDA -46.69M
EBIT n/a
Earnings Per Share (EPS) -1.33
Full Income Statement

Balance Sheet

The company has 18.26M in cash and 1.25M in debt, giving a net cash position of 17.01M.

Cash & Cash Equivalents 18.26M
Total Debt 1.25M
Net Cash 17.01M
Retained Earnings -437.41M
Total Assets 8.90M
Working Capital 7.99M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -44.85M and capital expenditures -59.00K, giving a free cash flow of -44.91M.

Operating Cash Flow -44.85M
Capital Expenditures -59.00K
Free Cash Flow -44.91M
FCF Per Share -1.01
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

GRTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -2660%
FCF Yield -1790.92%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for GRTX.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Scores

Altman Z-Score -77.23
Piotroski F-Score 3